25.91
전일 마감가:
$25.08
열려 있는:
$25.36
하루 거래량:
652.14K
Relative Volume:
1.20
시가총액:
$1.24B
수익:
$151.91M
순이익/손실:
$-46.03M
주가수익비율:
-25.65
EPS:
-1.01
순현금흐름:
$5.65M
1주 성능:
+6.45%
1개월 성능:
+21.02%
6개월 성능:
-2.85%
1년 성능:
+5.97%
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
BLFS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BLFS
Biolife Solutions Inc
|
25.91 | 1.17B | 151.91M | -46.03M | 5.65M | -1.01 |
![]()
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
![]()
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-22 | 재개 | Stephens | Overweight |
2024-09-30 | 개시 | H.C. Wainwright | Buy |
2024-04-04 | 개시 | Jefferies | Buy |
2023-07-11 | 개시 | Craig Hallum | Buy |
2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-10-19 | 개시 | B. Riley Securities | Buy |
2021-10-15 | 재개 | Cowen | Outperform |
2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-09-18 | 개시 | Cowen | Outperform |
2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2020-07-08 | 재확인 | Maxim Group | Buy |
2020-02-24 | 개시 | Lake Street | Buy |
2020-02-19 | 개시 | The Benchmark Company | Buy |
2020-02-06 | 재개 | B. Riley FBR | Buy |
2020-01-08 | 개시 | Stephens | Overweight |
2019-11-21 | 개시 | Oppenheimer | Outperform |
2019-07-22 | 개시 | H.C. Wainwright | Buy |
2017-11-10 | 재확인 | Maxim Group | Buy |
2017-09-19 | 재확인 | Maxim Group | Buy |
2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
2017-03-10 | 재확인 | Maxim Group | Buy |
2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
Is BioLife Solutions Inc. showing signs of accumulationEarnings Risk Report & Safe Entry Zone Identification - Newser
Market reaction to BioLife Solutions Inc.’s recent newsGold Moves & Fast Entry Momentum Trade Alerts - Newser
Can you recover from losses in BioLife Solutions Inc.July 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
Technical signs of recovery in BioLife Solutions Inc.Trade Risk Report & Safe Entry Point Identification - Newser
How to use Fibonacci retracement on BioLife Solutions Inc.Gap Up & Community Consensus Trade Alerts - Newser
Should you hold or exit BioLife Solutions Inc. nowMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - Newser
Using AI based signals to follow BioLife Solutions Inc.Quarterly Investment Review & Daily Oversold Bounce Ideas - Newser
Is BioLife Solutions Inc. a candidate for recovery playJuly 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why - MSN
Is BioLife Solutions Inc. meeting your algorithmic filter criteria2025 Price Action Summary & Detailed Earnings Play Alerts - Newser
Candlestick signals on BioLife Solutions Inc. stock todayTrade Ideas & Daily Stock Momentum Reports - Newser
Tools to monitor BioLife Solutions Inc. recovery probabilityWeekly Investment Recap & Daily Stock Momentum Reports - Newser
Does BioLife Solutions Inc. have a competitive edge2025 Market Trends & Free Real-Time Market Sentiment Alerts - sundaytimes.kr
Is this a good reentry point in BioLife Solutions Inc.Share Buyback & Free Verified High Yield Trade Plans - Newser
BioLife Solutions Inc. Charts Flash Early Recovery SignalsJuly 2025 Technicals & Low Drawdown Momentum Trade Ideas - beatles.ru
Reversal indicators forming on BioLife Solutions Inc. stock2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems And MariMed - Barchart.com
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed - The Globe and Mail
What are BioLife Solutions Inc.’s earnings expectationsLayoff News & Technical Pattern Based Signals - sundaytimes.kr
How to monitor BioLife Solutions Inc. with trend dashboardsQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
BioLife Solutions Inc. Enters Reversal Setup in Weekly ChartsTrade Risk Assessment & Free AI Powered Buy and Sell Recommendations - 선데이타임즈
Major Shareholder Sells Off BioLife Solutions Stock in Multi-Million Dollar Move! - TipRanks
Casdin Partners sells BioLife Solutions NASDAQ:BLFS shares for $11.3m - Investing.com Nigeria
Casdin Partners Sells 500k Shares in Biolife Solutions at $22.6/Share. - AInvest
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - NewsBreak: Local News & Alerts
Natixis Advisors LLC Takes $281,000 Position in BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
BioLife Solutions Reports Strong Q2 Growth Amid Challenges - MSN
BioLife (BLFS) Is Up 16.1% After Raising 2025 Guidance and Reporting Strong Q2 Results - simplywall.st
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2025 Earnings Call Transcript - Insider Monkey
Analysts Weigh In on Green Thumb Industries, Doximity, and BioLife Solutions - AInvest
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates - MSN
BioLife Solutions Reports Strong Q2 2025 Growth - TipRanks
What You Can Learn From BioLife Solutions, Inc.'s (NASDAQ:BLFS) P/S - 富途牛牛
BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - goSkagit
Regression analysis insights on BioLife Solutions Inc. performanceAI Intraday Market Movement Prediction Tool - Newser
Will BioLife Solutions Inc. rebound enough to break evenWeekly Stock Market Strategy Summary - Newser
BioLife Solutions (NASDAQ:BLFS) Given “Buy” Rating at HC Wainwright - Defense World
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2 - MSN
A Quick Look at Today's Ratings for BioLife Solutions(BLFS.US), With a Forecast Between $30 to $32 - 富途牛牛
BioLife Solutions Receives Buy Rating from Northland Securities, Price Target at $31.00 - AInvest
BioLife Solutions (BLFS) Is Up 9.0% After Raising 2025 Revenue Outlook Has The Bull Case Changed? - simplywall.st
BioLife Solutions Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Is BioLife Solutions (NASDAQ:BLFS) A Risky Investment? - simplywall.st
BioLife Solutions (NASDAQ:BLFS) Trading 12.5% Higher on Analyst Upgrade - Defense World
How to use a screener to detect BioLife Solutions Inc. breakoutsDaily Trade Monitor with Pattern Alerts - Newser
BioLife Solutions 2025 Q2 Earnings Loss Narrows 23.6% as Revenue Rises 28.9% - AInvest
BioLife Solutions Raises 2025 Revenue Guidance to $100M-$103M on Cell Processing Momentum - AInvest
BioLife Solutions Surges 11.43% on Earnings Volatility and Sector Uncertainty: What's Fueling the Momentum? - AInvest
BioLife Solutions: HC Wainwright Raises PT to $32, Maintains Buy Rating - AInvest
Earnings call transcript: BioLife Solutions Q2 2025 sees EPS miss, raises revenue guidance - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
바이오라이프 솔루션즈 주식 (BLFS) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Casdin Partners Master Fund, L | 10% Owner |
Aug 11 '25 |
Sale |
22.60 |
500,000 |
11,300,000 |
7,207,165 |
자본화:
|
볼륨(24시간):